By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Topical steroids > Fluocinonide > Fluocinonide Topical Dosage
Topical steroids
https://themeditary.com/dosage-information/fluocinonide-topical-dosage-465.html

Fluocinonide Topical Dosage

Drug Detail:Fluocinonide (Fluocinonide topical [ floo-oh-sin-oh-nide ])

Drug Class: Topical steroids

Contents
Uses Warnings Before Taking Dosage Side effects Interactions FAQ

Usual Adult Dose for Dermatitis

0.05% cream, gel, ointment: Apply a thin layer to affected area two to four times a day

0.1% cream: Apply a thin layer to affected area once or twice a day

Comments:

  • Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
  • Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses

Usual Adult Dose for Eczema

0.05% cream, gel, ointment: Apply a thin layer to affected area two to four times a day

0.1% cream: Apply a thin layer to affected area once or twice a day

Comments:

  • Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
  • Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses

Usual Adult Dose for Atopic Dermatitis

0.1% cream: Apply a thin layer to affected area once a day

Comments:

  • Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
  • Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Use: Relief of the inflammatory and pruritic manifestations of atopic dermatitis

Usual Adult Dose for Psoriasis

0.1% cream: Apply a thin layer to affected area once or twice a day

Comments:

  • Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
  • Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Use: Relief of the inflammatory and pruritic manifestations of psoriasis

Usual Pediatric Dose for Dermatitis

12 years or older:
0.05% cream, gel, ointment: Apply a thin layer to affected area two to four times a day

0.1% cream: Apply a thin layer to affected area once or twice a day

Comments:

  • Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
  • Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses

Usual Pediatric Dose for Eczema

12 years or older:
0.05% cream, gel, ointment: Apply a thin layer to affected area two to four times a day

0.1% cream: Apply a thin layer to affected area once or twice a day

Comments:

  • Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
  • Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses

Usual Pediatric Dose for Psoriasis

12 years or older:
0.1% cream: Apply a thin layer to affected area once or twice a day

Comments:

  • Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
  • Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Use: Relief of the inflammatory and pruritic manifestations of psoriasis

Usual Pediatric Dose for Atopic Dermatitis

12 years or older:
0.1% cream: Apply a thin layer to affected area once a day

Comments:

  • Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
  • Treatment should be limited to 2 consecutive weeks and no more than 60 g per week should be used.

Use: Relief of the inflammatory and pruritic manifestations of atopic dermatitis

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 12 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • This drug should not be used on the face, groin, or axillae.
  • The treated area should not be bandaged, covered, or wrapped, as to be occlusive, unless directed by a healthcare provider.
  • Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area.

Storage requirements:
  • Excessive heat should be avoided.

General:
  • This drug should not be used in the treatment of rosacea or perioral dermatitis.

Monitoring:
  • Endocrine: HPA-axis suppression (Urinary free-cortisol test, ACTH-stimulation test)

Patient advice:
  • Patients should report any signs of local adverse reactions, especially those that develop under occlusive dressings.

Frequently asked questions

  • Is it used for hair loss?
  • What is a substitute for fluocinonide cream?
  • What causes Plaque Psoriasis?
  • Is fluocinonide safe to use on your face?
  • Is fluocinonide an antifungal cream?
  • How long should you use fluocinonide for?
  • What is fluocinonide cream good for?
  • Is it a steroid?
  • Can fluocinonide be used to treat a poison ivy rash?
  • Is this an antibiotic?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by